nodes	percent_of_prediction	percent_of_DWPC	metapath
Clindamycin—CYP3A4—Bexarotene—hematologic cancer	0.0536	0.0829	CbGbCtD
Clindamycin—CYP3A4—Lomustine—hematologic cancer	0.0498	0.0771	CbGbCtD
Clindamycin—CYP3A4—Busulfan—hematologic cancer	0.0498	0.0771	CbGbCtD
Clindamycin—CYP3A4—Thiotepa—hematologic cancer	0.0444	0.0687	CbGbCtD
Clindamycin—CYP3A4—Methoxsalen—hematologic cancer	0.0345	0.0534	CbGbCtD
Clindamycin—CYP3A4—Bortezomib—hematologic cancer	0.0328	0.0508	CbGbCtD
Clindamycin—CYP3A4—Daunorubicin—hematologic cancer	0.0314	0.0486	CbGbCtD
Clindamycin—CYP3A4—Cytarabine—hematologic cancer	0.0277	0.0429	CbGbCtD
Clindamycin—CYP3A4—Teniposide—hematologic cancer	0.0273	0.0422	CbGbCtD
Clindamycin—CYP3A4—Ifosfamide—hematologic cancer	0.0252	0.039	CbGbCtD
Clindamycin—CYP3A4—Imatinib—hematologic cancer	0.0241	0.0372	CbGbCtD
Clindamycin—CYP3A4—Ruxolitinib—hematologic cancer	0.0227	0.0351	CbGbCtD
Clindamycin—CYP3A4—Nilotinib—hematologic cancer	0.0219	0.0338	CbGbCtD
Clindamycin—CYP3A4—Vinorelbine—hematologic cancer	0.0217	0.0335	CbGbCtD
Clindamycin—CYP3A4—Triamcinolone—hematologic cancer	0.0198	0.0307	CbGbCtD
Clindamycin—CYP3A4—Dasatinib—hematologic cancer	0.0193	0.0299	CbGbCtD
Clindamycin—CYP3A4—Mitoxantrone—hematologic cancer	0.0191	0.0295	CbGbCtD
Clindamycin—CYP3A4—Betamethasone—hematologic cancer	0.017	0.0263	CbGbCtD
Clindamycin—CYP3A4—Prednisolone—hematologic cancer	0.0168	0.026	CbGbCtD
Clindamycin—CYP3A4—Prednisone—hematologic cancer	0.0159	0.0245	CbGbCtD
Clindamycin—CYP3A4—Irinotecan—hematologic cancer	0.015	0.0233	CbGbCtD
Clindamycin—CYP3A4—Vinblastine—hematologic cancer	0.0134	0.0207	CbGbCtD
Clindamycin—CYP3A4—Vincristine—hematologic cancer	0.0131	0.0203	CbGbCtD
Clindamycin—CYP3A4—Etoposide—hematologic cancer	0.012	0.0186	CbGbCtD
Clindamycin—CYP3A4—Dexamethasone—hematologic cancer	0.0099	0.0153	CbGbCtD
Clindamycin—CYP3A4—Doxorubicin—hematologic cancer	0.00821	0.0127	CbGbCtD
Clindamycin—Anaphylactic shock—Dexamethasone—hematologic cancer	5.72e-05	0.000162	CcSEcCtD
Clindamycin—Diarrhoea—Mitoxantrone—hematologic cancer	5.71e-05	0.000162	CcSEcCtD
Clindamycin—Diarrhoea—Irinotecan—hematologic cancer	5.71e-05	0.000162	CcSEcCtD
Clindamycin—Vomiting—Carmustine—hematologic cancer	5.71e-05	0.000162	CcSEcCtD
Clindamycin—Agranulocytosis—Epirubicin—hematologic cancer	5.7e-05	0.000161	CcSEcCtD
Clindamycin—Gastrointestinal pain—Etoposide—hematologic cancer	5.68e-05	0.000161	CcSEcCtD
Clindamycin—Dizziness—Vincristine—hematologic cancer	5.67e-05	0.00016	CcSEcCtD
Clindamycin—Rash—Carmustine—hematologic cancer	5.66e-05	0.00016	CcSEcCtD
Clindamycin—Dermatitis—Carmustine—hematologic cancer	5.66e-05	0.00016	CcSEcCtD
Clindamycin—Vomiting—Alitretinoin—hematologic cancer	5.66e-05	0.00016	CcSEcCtD
Clindamycin—Anaemia—Prednisone—hematologic cancer	5.64e-05	0.000159	CcSEcCtD
Clindamycin—Headache—Carmustine—hematologic cancer	5.63e-05	0.000159	CcSEcCtD
Clindamycin—Dyspnoea—Triamcinolone—hematologic cancer	5.62e-05	0.000159	CcSEcCtD
Clindamycin—Rash—Alitretinoin—hematologic cancer	5.61e-05	0.000159	CcSEcCtD
Clindamycin—Dermatitis—Alitretinoin—hematologic cancer	5.61e-05	0.000159	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	5.6e-05	0.000158	CcSEcCtD
Clindamycin—Thrombocytopenia—Dexamethasone—hematologic cancer	5.6e-05	0.000158	CcSEcCtD
Clindamycin—Thrombocytopenia—Betamethasone—hematologic cancer	5.6e-05	0.000158	CcSEcCtD
Clindamycin—Vomiting—Ifosfamide—hematologic cancer	5.59e-05	0.000158	CcSEcCtD
Clindamycin—Hypersensitivity—Cisplatin—hematologic cancer	5.59e-05	0.000158	CcSEcCtD
Clindamycin—Headache—Alitretinoin—hematologic cancer	5.57e-05	0.000158	CcSEcCtD
Clindamycin—Diarrhoea—Gemcitabine—hematologic cancer	5.57e-05	0.000157	CcSEcCtD
Clindamycin—Nausea—Thalidomide—hematologic cancer	5.56e-05	0.000157	CcSEcCtD
Clindamycin—Dyspepsia—Triamcinolone—hematologic cancer	5.55e-05	0.000157	CcSEcCtD
Clindamycin—Rash—Ifosfamide—hematologic cancer	5.55e-05	0.000157	CcSEcCtD
Clindamycin—Dermatitis—Ifosfamide—hematologic cancer	5.54e-05	0.000157	CcSEcCtD
Clindamycin—Erythema multiforme—Methotrexate—hematologic cancer	5.54e-05	0.000157	CcSEcCtD
Clindamycin—Dizziness—Irinotecan—hematologic cancer	5.52e-05	0.000156	CcSEcCtD
Clindamycin—Urticaria—Etoposide—hematologic cancer	5.52e-05	0.000156	CcSEcCtD
Clindamycin—Jaundice—Doxorubicin—hematologic cancer	5.51e-05	0.000156	CcSEcCtD
Clindamycin—Abdominal pain—Etoposide—hematologic cancer	5.49e-05	0.000155	CcSEcCtD
Clindamycin—Body temperature increased—Etoposide—hematologic cancer	5.49e-05	0.000155	CcSEcCtD
Clindamycin—Urinary tract infection—Doxorubicin—hematologic cancer	5.49e-05	0.000155	CcSEcCtD
Clindamycin—Vertigo—Prednisone—hematologic cancer	5.48e-05	0.000155	CcSEcCtD
Clindamycin—Vomiting—Vincristine—hematologic cancer	5.45e-05	0.000154	CcSEcCtD
Clindamycin—Urticaria—Prednisolone—hematologic cancer	5.44e-05	0.000154	CcSEcCtD
Clindamycin—Asthenia—Cisplatin—hematologic cancer	5.44e-05	0.000154	CcSEcCtD
Clindamycin—Fatigue—Triamcinolone—hematologic cancer	5.43e-05	0.000154	CcSEcCtD
Clindamycin—Rash—Vincristine—hematologic cancer	5.41e-05	0.000153	CcSEcCtD
Clindamycin—Dermatitis—Vincristine—hematologic cancer	5.4e-05	0.000153	CcSEcCtD
Clindamycin—Pain—Triamcinolone—hematologic cancer	5.39e-05	0.000152	CcSEcCtD
Clindamycin—Headache—Vincristine—hematologic cancer	5.37e-05	0.000152	CcSEcCtD
Clindamycin—Hypotension—Dexamethasone—hematologic cancer	5.34e-05	0.000151	CcSEcCtD
Clindamycin—Hypotension—Betamethasone—hematologic cancer	5.34e-05	0.000151	CcSEcCtD
Clindamycin—Nausea—Carmustine—hematologic cancer	5.34e-05	0.000151	CcSEcCtD
Clindamycin—Epistaxis—Doxorubicin—hematologic cancer	5.33e-05	0.000151	CcSEcCtD
Clindamycin—Vomiting—Mitoxantrone—hematologic cancer	5.31e-05	0.00015	CcSEcCtD
Clindamycin—Vomiting—Irinotecan—hematologic cancer	5.31e-05	0.00015	CcSEcCtD
Clindamycin—Nausea—Alitretinoin—hematologic cancer	5.29e-05	0.00015	CcSEcCtD
Clindamycin—Agranulocytosis—Doxorubicin—hematologic cancer	5.27e-05	0.000149	CcSEcCtD
Clindamycin—Hypertension—Prednisone—hematologic cancer	5.27e-05	0.000149	CcSEcCtD
Clindamycin—Rash—Mitoxantrone—hematologic cancer	5.27e-05	0.000149	CcSEcCtD
Clindamycin—Rash—Irinotecan—hematologic cancer	5.27e-05	0.000149	CcSEcCtD
Clindamycin—Dermatitis—Mitoxantrone—hematologic cancer	5.26e-05	0.000149	CcSEcCtD
Clindamycin—Dermatitis—Irinotecan—hematologic cancer	5.26e-05	0.000149	CcSEcCtD
Clindamycin—Headache—Irinotecan—hematologic cancer	5.23e-05	0.000148	CcSEcCtD
Clindamycin—Headache—Mitoxantrone—hematologic cancer	5.23e-05	0.000148	CcSEcCtD
Clindamycin—Nausea—Ifosfamide—hematologic cancer	5.22e-05	0.000148	CcSEcCtD
Clindamycin—Diarrhoea—Cisplatin—hematologic cancer	5.19e-05	0.000147	CcSEcCtD
Clindamycin—Erythema multiforme—Epirubicin—hematologic cancer	5.18e-05	0.000147	CcSEcCtD
Clindamycin—Vomiting—Gemcitabine—hematologic cancer	5.17e-05	0.000146	CcSEcCtD
Clindamycin—Discomfort—Prednisone—hematologic cancer	5.13e-05	0.000145	CcSEcCtD
Clindamycin—Rash—Gemcitabine—hematologic cancer	5.13e-05	0.000145	CcSEcCtD
Clindamycin—Dermatitis—Gemcitabine—hematologic cancer	5.12e-05	0.000145	CcSEcCtD
Clindamycin—Hypersensitivity—Etoposide—hematologic cancer	5.12e-05	0.000145	CcSEcCtD
Clindamycin—Erythema—Methotrexate—hematologic cancer	5.1e-05	0.000144	CcSEcCtD
Clindamycin—Headache—Gemcitabine—hematologic cancer	5.1e-05	0.000144	CcSEcCtD
Clindamycin—Nausea—Vincristine—hematologic cancer	5.09e-05	0.000144	CcSEcCtD
Clindamycin—Flushing—Epirubicin—hematologic cancer	5.09e-05	0.000144	CcSEcCtD
Clindamycin—Hypersensitivity—Prednisolone—hematologic cancer	5.05e-05	0.000143	CcSEcCtD
Clindamycin—Dyspepsia—Betamethasone—hematologic cancer	5.03e-05	0.000142	CcSEcCtD
Clindamycin—Dyspepsia—Dexamethasone—hematologic cancer	5.03e-05	0.000142	CcSEcCtD
Clindamycin—Urticaria—Triamcinolone—hematologic cancer	5.01e-05	0.000142	CcSEcCtD
Clindamycin—Dysgeusia—Methotrexate—hematologic cancer	4.99e-05	0.000141	CcSEcCtD
Clindamycin—Asthenia—Etoposide—hematologic cancer	4.98e-05	0.000141	CcSEcCtD
Clindamycin—Body temperature increased—Triamcinolone—hematologic cancer	4.98e-05	0.000141	CcSEcCtD
Clindamycin—Anaphylactic shock—Prednisone—hematologic cancer	4.98e-05	0.000141	CcSEcCtD
Clindamycin—Nausea—Mitoxantrone—hematologic cancer	4.96e-05	0.00014	CcSEcCtD
Clindamycin—Nausea—Irinotecan—hematologic cancer	4.96e-05	0.00014	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.94e-05	0.00014	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.94e-05	0.00014	CcSEcCtD
Clindamycin—Back pain—Methotrexate—hematologic cancer	4.93e-05	0.000139	CcSEcCtD
Clindamycin—Fatigue—Dexamethasone—hematologic cancer	4.93e-05	0.000139	CcSEcCtD
Clindamycin—Fatigue—Betamethasone—hematologic cancer	4.93e-05	0.000139	CcSEcCtD
Clindamycin—Pruritus—Etoposide—hematologic cancer	4.91e-05	0.000139	CcSEcCtD
Clindamycin—Pain—Betamethasone—hematologic cancer	4.89e-05	0.000138	CcSEcCtD
Clindamycin—Pain—Dexamethasone—hematologic cancer	4.89e-05	0.000138	CcSEcCtD
Clindamycin—Nausea—Gemcitabine—hematologic cancer	4.83e-05	0.000137	CcSEcCtD
Clindamycin—Vomiting—Cisplatin—hematologic cancer	4.82e-05	0.000136	CcSEcCtD
Clindamycin—Erythema multiforme—Doxorubicin—hematologic cancer	4.79e-05	0.000136	CcSEcCtD
Clindamycin—Rash—Cisplatin—hematologic cancer	4.78e-05	0.000135	CcSEcCtD
Clindamycin—Dermatitis—Cisplatin—hematologic cancer	4.78e-05	0.000135	CcSEcCtD
Clindamycin—Erythema—Epirubicin—hematologic cancer	4.77e-05	0.000135	CcSEcCtD
Clindamycin—Diarrhoea—Etoposide—hematologic cancer	4.75e-05	0.000134	CcSEcCtD
Clindamycin—Anaemia—Methotrexate—hematologic cancer	4.71e-05	0.000133	CcSEcCtD
Clindamycin—Flushing—Doxorubicin—hematologic cancer	4.71e-05	0.000133	CcSEcCtD
Clindamycin—Flatulence—Epirubicin—hematologic cancer	4.7e-05	0.000133	CcSEcCtD
Clindamycin—Gastrointestinal pain—Betamethasone—hematologic cancer	4.67e-05	0.000132	CcSEcCtD
Clindamycin—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.67e-05	0.000132	CcSEcCtD
Clindamycin—Dysgeusia—Epirubicin—hematologic cancer	4.67e-05	0.000132	CcSEcCtD
Clindamycin—Hypersensitivity—Triamcinolone—hematologic cancer	4.64e-05	0.000131	CcSEcCtD
Clindamycin—Back pain—Epirubicin—hematologic cancer	4.62e-05	0.000131	CcSEcCtD
Clindamycin—Dizziness—Etoposide—hematologic cancer	4.59e-05	0.00013	CcSEcCtD
Clindamycin—Muscle spasms—Epirubicin—hematologic cancer	4.59e-05	0.00013	CcSEcCtD
Clindamycin—Vertigo—Methotrexate—hematologic cancer	4.58e-05	0.00013	CcSEcCtD
Clindamycin—Leukopenia—Methotrexate—hematologic cancer	4.56e-05	0.000129	CcSEcCtD
Clindamycin—Urticaria—Betamethasone—hematologic cancer	4.54e-05	0.000128	CcSEcCtD
Clindamycin—Urticaria—Dexamethasone—hematologic cancer	4.54e-05	0.000128	CcSEcCtD
Clindamycin—Dizziness—Prednisolone—hematologic cancer	4.53e-05	0.000128	CcSEcCtD
Clindamycin—Asthenia—Triamcinolone—hematologic cancer	4.52e-05	0.000128	CcSEcCtD
Clindamycin—Body temperature increased—Dexamethasone—hematologic cancer	4.52e-05	0.000128	CcSEcCtD
Clindamycin—Abdominal pain—Betamethasone—hematologic cancer	4.52e-05	0.000128	CcSEcCtD
Clindamycin—Abdominal pain—Dexamethasone—hematologic cancer	4.52e-05	0.000128	CcSEcCtD
Clindamycin—Body temperature increased—Betamethasone—hematologic cancer	4.52e-05	0.000128	CcSEcCtD
Clindamycin—Nausea—Cisplatin—hematologic cancer	4.5e-05	0.000127	CcSEcCtD
Clindamycin—Pruritus—Triamcinolone—hematologic cancer	4.46e-05	0.000126	CcSEcCtD
Clindamycin—Vomiting—Etoposide—hematologic cancer	4.42e-05	0.000125	CcSEcCtD
Clindamycin—Erythema—Doxorubicin—hematologic cancer	4.41e-05	0.000125	CcSEcCtD
Clindamycin—Anaemia—Epirubicin—hematologic cancer	4.41e-05	0.000125	CcSEcCtD
Clindamycin—Dyspepsia—Prednisone—hematologic cancer	4.38e-05	0.000124	CcSEcCtD
Clindamycin—Rash—Etoposide—hematologic cancer	4.38e-05	0.000124	CcSEcCtD
Clindamycin—Dermatitis—Etoposide—hematologic cancer	4.38e-05	0.000124	CcSEcCtD
Clindamycin—Headache—Etoposide—hematologic cancer	4.35e-05	0.000123	CcSEcCtD
Clindamycin—Flatulence—Doxorubicin—hematologic cancer	4.35e-05	0.000123	CcSEcCtD
Clindamycin—Dysgeusia—Doxorubicin—hematologic cancer	4.32e-05	0.000122	CcSEcCtD
Clindamycin—Rash—Prednisolone—hematologic cancer	4.32e-05	0.000122	CcSEcCtD
Clindamycin—Dermatitis—Prednisolone—hematologic cancer	4.32e-05	0.000122	CcSEcCtD
Clindamycin—Fatigue—Prednisone—hematologic cancer	4.29e-05	0.000121	CcSEcCtD
Clindamycin—Headache—Prednisolone—hematologic cancer	4.29e-05	0.000121	CcSEcCtD
Clindamycin—Discomfort—Methotrexate—hematologic cancer	4.29e-05	0.000121	CcSEcCtD
Clindamycin—Vertigo—Epirubicin—hematologic cancer	4.29e-05	0.000121	CcSEcCtD
Clindamycin—Leukopenia—Epirubicin—hematologic cancer	4.27e-05	0.000121	CcSEcCtD
Clindamycin—Back pain—Doxorubicin—hematologic cancer	4.27e-05	0.000121	CcSEcCtD
Clindamycin—Constipation—Prednisone—hematologic cancer	4.26e-05	0.00012	CcSEcCtD
Clindamycin—Muscle spasms—Doxorubicin—hematologic cancer	4.24e-05	0.00012	CcSEcCtD
Clindamycin—Dizziness—Triamcinolone—hematologic cancer	4.17e-05	0.000118	CcSEcCtD
Clindamycin—Anaphylactic shock—Methotrexate—hematologic cancer	4.16e-05	0.000118	CcSEcCtD
Clindamycin—Nausea—Etoposide—hematologic cancer	4.13e-05	0.000117	CcSEcCtD
Clindamycin—Hypertension—Epirubicin—hematologic cancer	4.12e-05	0.000117	CcSEcCtD
Clindamycin—Asthenia—Dexamethasone—hematologic cancer	4.1e-05	0.000116	CcSEcCtD
Clindamycin—Asthenia—Betamethasone—hematologic cancer	4.1e-05	0.000116	CcSEcCtD
Clindamycin—Anaemia—Doxorubicin—hematologic cancer	4.08e-05	0.000115	CcSEcCtD
Clindamycin—Thrombocytopenia—Methotrexate—hematologic cancer	4.07e-05	0.000115	CcSEcCtD
Clindamycin—Gastrointestinal pain—Prednisone—hematologic cancer	4.07e-05	0.000115	CcSEcCtD
Clindamycin—Nausea—Prednisolone—hematologic cancer	4.07e-05	0.000115	CcSEcCtD
Clindamycin—Pruritus—Betamethasone—hematologic cancer	4.04e-05	0.000114	CcSEcCtD
Clindamycin—Pruritus—Dexamethasone—hematologic cancer	4.04e-05	0.000114	CcSEcCtD
Clindamycin—Discomfort—Epirubicin—hematologic cancer	4.01e-05	0.000114	CcSEcCtD
Clindamycin—Vomiting—Triamcinolone—hematologic cancer	4.01e-05	0.000113	CcSEcCtD
Clindamycin—Rash—Triamcinolone—hematologic cancer	3.97e-05	0.000112	CcSEcCtD
Clindamycin—Dermatitis—Triamcinolone—hematologic cancer	3.97e-05	0.000112	CcSEcCtD
Clindamycin—Vertigo—Doxorubicin—hematologic cancer	3.97e-05	0.000112	CcSEcCtD
Clindamycin—Urticaria—Prednisone—hematologic cancer	3.96e-05	0.000112	CcSEcCtD
Clindamycin—Leukopenia—Doxorubicin—hematologic cancer	3.95e-05	0.000112	CcSEcCtD
Clindamycin—Headache—Triamcinolone—hematologic cancer	3.95e-05	0.000112	CcSEcCtD
Clindamycin—Abdominal pain—Prednisone—hematologic cancer	3.94e-05	0.000111	CcSEcCtD
Clindamycin—Body temperature increased—Prednisone—hematologic cancer	3.94e-05	0.000111	CcSEcCtD
Clindamycin—Diarrhoea—Dexamethasone—hematologic cancer	3.91e-05	0.000111	CcSEcCtD
Clindamycin—Diarrhoea—Betamethasone—hematologic cancer	3.91e-05	0.000111	CcSEcCtD
Clindamycin—Anaphylactic shock—Epirubicin—hematologic cancer	3.89e-05	0.00011	CcSEcCtD
Clindamycin—Hypotension—Methotrexate—hematologic cancer	3.89e-05	0.00011	CcSEcCtD
Clindamycin—Thrombocytopenia—Epirubicin—hematologic cancer	3.81e-05	0.000108	CcSEcCtD
Clindamycin—Hypertension—Doxorubicin—hematologic cancer	3.81e-05	0.000108	CcSEcCtD
Clindamycin—Dizziness—Dexamethasone—hematologic cancer	3.78e-05	0.000107	CcSEcCtD
Clindamycin—Dizziness—Betamethasone—hematologic cancer	3.78e-05	0.000107	CcSEcCtD
Clindamycin—Nausea—Triamcinolone—hematologic cancer	3.74e-05	0.000106	CcSEcCtD
Clindamycin—Discomfort—Doxorubicin—hematologic cancer	3.71e-05	0.000105	CcSEcCtD
Clindamycin—Dyspnoea—Methotrexate—hematologic cancer	3.71e-05	0.000105	CcSEcCtD
Clindamycin—Hypersensitivity—Prednisone—hematologic cancer	3.67e-05	0.000104	CcSEcCtD
Clindamycin—Dyspepsia—Methotrexate—hematologic cancer	3.66e-05	0.000104	CcSEcCtD
Clindamycin—Hypotension—Epirubicin—hematologic cancer	3.64e-05	0.000103	CcSEcCtD
Clindamycin—Vomiting—Dexamethasone—hematologic cancer	3.63e-05	0.000103	CcSEcCtD
Clindamycin—Vomiting—Betamethasone—hematologic cancer	3.63e-05	0.000103	CcSEcCtD
Clindamycin—Rash—Betamethasone—hematologic cancer	3.6e-05	0.000102	CcSEcCtD
Clindamycin—Rash—Dexamethasone—hematologic cancer	3.6e-05	0.000102	CcSEcCtD
Clindamycin—Anaphylactic shock—Doxorubicin—hematologic cancer	3.6e-05	0.000102	CcSEcCtD
Clindamycin—Dermatitis—Dexamethasone—hematologic cancer	3.6e-05	0.000102	CcSEcCtD
Clindamycin—Dermatitis—Betamethasone—hematologic cancer	3.6e-05	0.000102	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.59e-05	0.000102	CcSEcCtD
Clindamycin—Fatigue—Methotrexate—hematologic cancer	3.59e-05	0.000101	CcSEcCtD
Clindamycin—Headache—Betamethasone—hematologic cancer	3.58e-05	0.000101	CcSEcCtD
Clindamycin—Headache—Dexamethasone—hematologic cancer	3.58e-05	0.000101	CcSEcCtD
Clindamycin—Asthenia—Prednisone—hematologic cancer	3.57e-05	0.000101	CcSEcCtD
Clindamycin—Pain—Methotrexate—hematologic cancer	3.56e-05	0.000101	CcSEcCtD
Clindamycin—Thrombocytopenia—Doxorubicin—hematologic cancer	3.53e-05	9.98e-05	CcSEcCtD
Clindamycin—Pruritus—Prednisone—hematologic cancer	3.52e-05	9.96e-05	CcSEcCtD
Clindamycin—Dyspnoea—Epirubicin—hematologic cancer	3.47e-05	9.82e-05	CcSEcCtD
Clindamycin—Dyspepsia—Epirubicin—hematologic cancer	3.43e-05	9.69e-05	CcSEcCtD
Clindamycin—Diarrhoea—Prednisone—hematologic cancer	3.41e-05	9.63e-05	CcSEcCtD
Clindamycin—Gastrointestinal pain—Methotrexate—hematologic cancer	3.4e-05	9.62e-05	CcSEcCtD
Clindamycin—Nausea—Dexamethasone—hematologic cancer	3.4e-05	9.6e-05	CcSEcCtD
Clindamycin—Nausea—Betamethasone—hematologic cancer	3.4e-05	9.6e-05	CcSEcCtD
Clindamycin—Hypotension—Doxorubicin—hematologic cancer	3.37e-05	9.52e-05	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.36e-05	9.51e-05	CcSEcCtD
Clindamycin—Fatigue—Epirubicin—hematologic cancer	3.36e-05	9.5e-05	CcSEcCtD
Clindamycin—Pain—Epirubicin—hematologic cancer	3.33e-05	9.42e-05	CcSEcCtD
Clindamycin—Constipation—Epirubicin—hematologic cancer	3.33e-05	9.42e-05	CcSEcCtD
Clindamycin—Urticaria—Methotrexate—hematologic cancer	3.31e-05	9.35e-05	CcSEcCtD
Clindamycin—Dizziness—Prednisone—hematologic cancer	3.29e-05	9.31e-05	CcSEcCtD
Clindamycin—Abdominal pain—Methotrexate—hematologic cancer	3.29e-05	9.3e-05	CcSEcCtD
Clindamycin—Body temperature increased—Methotrexate—hematologic cancer	3.29e-05	9.3e-05	CcSEcCtD
Clindamycin—Dyspnoea—Doxorubicin—hematologic cancer	3.21e-05	9.08e-05	CcSEcCtD
Clindamycin—Gastrointestinal pain—Epirubicin—hematologic cancer	3.18e-05	9.01e-05	CcSEcCtD
Clindamycin—Dyspepsia—Doxorubicin—hematologic cancer	3.17e-05	8.97e-05	CcSEcCtD
Clindamycin—Vomiting—Prednisone—hematologic cancer	3.17e-05	8.95e-05	CcSEcCtD
Clindamycin—Rash—Prednisone—hematologic cancer	3.14e-05	8.88e-05	CcSEcCtD
Clindamycin—Dermatitis—Prednisone—hematologic cancer	3.14e-05	8.87e-05	CcSEcCtD
Clindamycin—Headache—Prednisone—hematologic cancer	3.12e-05	8.82e-05	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.11e-05	8.8e-05	CcSEcCtD
Clindamycin—Fatigue—Doxorubicin—hematologic cancer	3.11e-05	8.79e-05	CcSEcCtD
Clindamycin—Urticaria—Epirubicin—hematologic cancer	3.09e-05	8.75e-05	CcSEcCtD
Clindamycin—Constipation—Doxorubicin—hematologic cancer	3.08e-05	8.71e-05	CcSEcCtD
Clindamycin—Pain—Doxorubicin—hematologic cancer	3.08e-05	8.71e-05	CcSEcCtD
Clindamycin—Body temperature increased—Epirubicin—hematologic cancer	3.08e-05	8.71e-05	CcSEcCtD
Clindamycin—Abdominal pain—Epirubicin—hematologic cancer	3.08e-05	8.71e-05	CcSEcCtD
Clindamycin—Hypersensitivity—Methotrexate—hematologic cancer	3.07e-05	8.67e-05	CcSEcCtD
Clindamycin—Asthenia—Methotrexate—hematologic cancer	2.99e-05	8.44e-05	CcSEcCtD
Clindamycin—Nausea—Prednisone—hematologic cancer	2.96e-05	8.36e-05	CcSEcCtD
Clindamycin—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.95e-05	8.33e-05	CcSEcCtD
Clindamycin—Pruritus—Methotrexate—hematologic cancer	2.94e-05	8.33e-05	CcSEcCtD
Clindamycin—Hypersensitivity—Epirubicin—hematologic cancer	2.87e-05	8.11e-05	CcSEcCtD
Clindamycin—Urticaria—Doxorubicin—hematologic cancer	2.86e-05	8.1e-05	CcSEcCtD
Clindamycin—Abdominal pain—Doxorubicin—hematologic cancer	2.85e-05	8.06e-05	CcSEcCtD
Clindamycin—Body temperature increased—Doxorubicin—hematologic cancer	2.85e-05	8.06e-05	CcSEcCtD
Clindamycin—Diarrhoea—Methotrexate—hematologic cancer	2.85e-05	8.05e-05	CcSEcCtD
Clindamycin—Asthenia—Epirubicin—hematologic cancer	2.79e-05	7.9e-05	CcSEcCtD
Clindamycin—Pruritus—Epirubicin—hematologic cancer	2.75e-05	7.79e-05	CcSEcCtD
Clindamycin—Dizziness—Methotrexate—hematologic cancer	2.75e-05	7.78e-05	CcSEcCtD
Clindamycin—Diarrhoea—Epirubicin—hematologic cancer	2.66e-05	7.54e-05	CcSEcCtD
Clindamycin—Hypersensitivity—Doxorubicin—hematologic cancer	2.65e-05	7.51e-05	CcSEcCtD
Clindamycin—Vomiting—Methotrexate—hematologic cancer	2.65e-05	7.48e-05	CcSEcCtD
Clindamycin—Rash—Methotrexate—hematologic cancer	2.62e-05	7.42e-05	CcSEcCtD
Clindamycin—Dermatitis—Methotrexate—hematologic cancer	2.62e-05	7.41e-05	CcSEcCtD
Clindamycin—Headache—Methotrexate—hematologic cancer	2.61e-05	7.37e-05	CcSEcCtD
Clindamycin—Asthenia—Doxorubicin—hematologic cancer	2.58e-05	7.31e-05	CcSEcCtD
Clindamycin—Dizziness—Epirubicin—hematologic cancer	2.57e-05	7.28e-05	CcSEcCtD
Clindamycin—Pruritus—Doxorubicin—hematologic cancer	2.55e-05	7.21e-05	CcSEcCtD
Clindamycin—Vomiting—Epirubicin—hematologic cancer	2.48e-05	7e-05	CcSEcCtD
Clindamycin—Nausea—Methotrexate—hematologic cancer	2.47e-05	6.99e-05	CcSEcCtD
Clindamycin—Diarrhoea—Doxorubicin—hematologic cancer	2.47e-05	6.97e-05	CcSEcCtD
Clindamycin—Rash—Epirubicin—hematologic cancer	2.46e-05	6.94e-05	CcSEcCtD
Clindamycin—Dermatitis—Epirubicin—hematologic cancer	2.45e-05	6.94e-05	CcSEcCtD
Clindamycin—Headache—Epirubicin—hematologic cancer	2.44e-05	6.9e-05	CcSEcCtD
Clindamycin—Dizziness—Doxorubicin—hematologic cancer	2.38e-05	6.74e-05	CcSEcCtD
Clindamycin—Nausea—Epirubicin—hematologic cancer	2.31e-05	6.54e-05	CcSEcCtD
Clindamycin—Vomiting—Doxorubicin—hematologic cancer	2.29e-05	6.48e-05	CcSEcCtD
Clindamycin—Rash—Doxorubicin—hematologic cancer	2.27e-05	6.43e-05	CcSEcCtD
Clindamycin—Dermatitis—Doxorubicin—hematologic cancer	2.27e-05	6.42e-05	CcSEcCtD
Clindamycin—Headache—Doxorubicin—hematologic cancer	2.26e-05	6.38e-05	CcSEcCtD
Clindamycin—Nausea—Doxorubicin—hematologic cancer	2.14e-05	6.05e-05	CcSEcCtD
